General Information of Drug (ID: DM6CWSO)

Drug Name
Defibrotide
Synonyms Defitelio; Defibrotide (iv, veno-occlusive disease); Defibrotide (iv, veno-occlusive disease), Gentium
Indication
Disease Entry ICD 11 Status REF
Hepatic veno-occlusive disease DB98.6 Approved [1]
Plasma cell myeloma 2A83.1 Approved [2]
Diabetic nephropathy GB61.Z Phase 3 [3]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [4]
Cross-matching ID
PubChem CID
135565962
TTD ID
D0FM2W
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (NDA) 208114
2 Defibrotide FDA Label
3 ClinicalTrials.gov (NCT00358501) Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients. U.S. National Institutes of Health.
4 ClinicalTrials.gov (NCT04335201) Defibrotide in COVID-19 Pneumonia. U.S. National Institutes of Health.